This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5g3m
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5g3m' size='340' side='right' caption='[[5g3m]], [[Resolution|resolution]] 1.85Å' scene=''> | <StructureSection load='5g3m' size='340' side='right' caption='[[5g3m]], [[Resolution|resolution]] 1.85Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5g3m]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5G3M OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5G3M FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5g3m]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5G3M OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5G3M FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=9JH:4-BENZYLBENZAMIDE'>9JH</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=9JH:4-BENZYLBENZAMIDE'>9JH</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5g3n|5g3n]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5g3n|5g3n]]</td></tr> | ||
| Line 20: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 5g3m" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5g3m" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Phospholipase A2|Phospholipase A2]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Bodin, C]] | [[Category: Bodin, C]] | ||
[[Category: Hallberg, K]] | [[Category: Hallberg, K]] | ||
Revision as of 06:46, 4 April 2018
Discovery of a novel secreted phospholipase A2 (sPLA2) inhibitor.
| |||||||||||
Categories: Human | Bodin, C | Hallberg, K | Sandmark, J | Cardiovascular disease | Fragment | Hydrolase | Inhibitor | Spla2
